When did Vericel report Q2 2025 earnings?

Vericel (VCEL) reported Q2 2025 earnings on July 31, 2025 before market open.

What were Vericel's Q2 2025 revenue and EPS?

Vericel reported revenue of $63.2M and eps of $-0.01 for Q2 2025.

Did Vericel beat estimates in Q2 2025?

Revenue missed the consensus estimate of $64.6M by $1.3M. EPS beat the consensus estimate of $-0.04 by $0.03.

How did Vericel's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 20.1% from $52.7M a year earlier and eps grew 90.0% from $-0.10.

Where can I find Vericel's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001628280-25-036859) directly on SEC EDGAR. The filing index links above go to sec.gov.

Vericel VCEL Q2 2025 earnings

Reported July 31, 2025 · Before market open

Revenue$63.2MMiss by $1.3M

EPS-$0.01Beat by $0.03

Revenue estimate$64.6M

EPS estimate-$0.04

Next report

Jul 30, 2026 (Tomorrow)

Revenue estimate$72.7M

EPS estimate-$0.04

Financials

Q2 2025

Income statement

See full

Revenue$63.2M+20.1%

Gross profit$46.6M+27.4%

Operating income-$2.0M+66.4%

Net income-$553.0K+88.2%

EPS (diluted)-$0.01+90.0%

Balance sheet

See full

Cash & equivalents$80.5M+6.2%

Total debt$100.4M+5.1%

Total equity$306.8M+26.3%

Total assets$435.6M+15.6%

Cash flow

See full

Operating cash flow$8.2M-55.7%

CapEx$8.1M-51.5%

Free cash flow$81.0K—

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$2.18B-2.2%

Enterprise value$2.2B-2.1%

P/E307×—

P/S8.8×-1.6×

Profitability

See full

Gross margin73.5%+3.1pp

Operating margin0.5%—

Net margin2.9%—

Returns & leverage

See full

Return on equity2.6%—

Debt / equity0.3×-0.1×

Current ratio5×+0.5×

Segments

By product

See full

M A C I Implants and kits$53.5M+21.1%

MACI implants, kits, and instruments$39.4M+28.4%

Epicel$8.6M+11.0%

Biopsy kits$642.0K+30.5%

Versus estimates

Revenue

Q1 2026$68.4MBeat by $4.7M Q4 2025$92.9MBeat by $1.9M Q3 2025$67.5MMiss by $25.2M

Q2 2025$63.2MMiss by $1.3M

Q1 2025$52.6MMiss by $12.2M Q4 2024$75.4MBeat by $17.3M

Diluted EPS

Q1 2026-$0.12Beat by $0.03 Q4 2025$0.45In line Q3 2025$0.10Beat by $0.12

Q2 2025-$0.01Beat by $0.03

Q1 2025-$0.23Miss by $0.14 Q4 2024$0.38Beat by $0.07

Ask the moment Vericel reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Vericel report Q2 2025 earnings?: Vericel (VCEL) reported Q2 2025 earnings on July 31, 2025 before market open.
What were Vericel's Q2 2025 revenue and EPS?: Vericel reported revenue of $63.2M and eps of $-0.01 for Q2 2025.
Did Vericel beat estimates in Q2 2025?: Revenue missed the consensus estimate of $64.6M by $1.3M. EPS beat the consensus estimate of $-0.04 by $0.03.
How did Vericel's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 20.1% from $52.7M a year earlier and eps grew 90.0% from $-0.10.
Where can I find Vericel's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001628280-25-036859) directly on SEC EDGAR. The filing index links above go to sec.gov.